The largest database of trusted experimental protocols

Micro fine insulin syringe

Manufactured by BD
Sourced in United Kingdom

The BD Micro-Fine insulin syringe is a medical device designed for the administration of insulin. It features a small, thin needle to facilitate comfortable and precise injection. The syringe is intended for single use and is available in various sizes to accommodate different insulin dosages.

Automatically generated - may contain errors

5 protocols using micro fine insulin syringe

1

Virulence Comparison of Aspergillus Strains

Check if the same lab product or an alternative is used in the 5 most similar protocols
Conidia suspensions of strain CBS144.89 (Dal), its bioluminescent KU80 deletion strain (ΔakuB N5) (Resendiz-Sharpe et al., 2022 (link)), as well as strain NIH4215 and its bioluminescent and nmt1-complemented ΔakuB strains 2/9 and 4/11 were freshly prepared from glucose/glutamine minimal medium slopes supplemented with or without thiamine. Conidia were harvested in PBS (Gibco) containing 0.01% Tween 20, washed twice and resuspended in PBS. Larvae of the greater wax moth Galleria mellonella (Waxworms Ltd - Sheffield, UK) were kept at 15°C for up to one week before starting the infection studies. To compare the virulence of wild-type strains and bioluminescent ΔakuB transformants, groups of 10 larvae weighing 200-300 mg were inoculated each with 50 µl PBS without (mock control) or with 1 × 105, 2.5 × 105, 5 × 105 or 1 × 106 conidia. Injections into the haemolymph were performed through the second pro-leg of G. mellonella larvae, using 0.5 mL BD Micro-Fine™ insulin syringes. In addition, a group of non-injected larvae served as treatment control. After infection the larvae were kept at 37°C in the dark and their survival was monitored daily for up to 6 days post-infection. The data was plotted in Kaplan-Meier survival curves and statistical analysis was performed by log-rank test using GraphPad Prism version 8.0.0 for Windows.
+ Open protocol
+ Expand
2

Intrathoracic Injection of Cell Suspension

Check if the same lab product or an alternative is used in the 5 most similar protocols
Syringes (BD microFine+ Insulin syringes) were prepared in advance by drawing 100 μl of PBS cell suspension into a 27 g low dead volume insulin syringe and air expelled. The final 5 mm of the needle tip was crooked at an 80° angle using a sterile forceps with bevel pointing out. The mouse was anaesthetised with isoflurane and the left thoracic region shaved with an electric clipper and sterilised. Injections were performed by piercing the skin at an intercostal space of lower left sternum with the point of the needle and injecting the solution, with the crook limiting the penetration to 5 mm. Mice were observed for pneumothorax for 30 mins after procedure. Mice that received improper injections (e.g. intradermal as evidenced by skin bulge at injection site) were removed from analysis.
+ Open protocol
+ Expand
3

Galleria mellonella Model for Candida albicans

Check if the same lab product or an alternative is used in the 5 most similar protocols
Galleria mellonella infections were performed as described previously (78 (link)). The wax moth Galleria mellonella was obtained from UK Waxworms, Ltd. (Sheffield, UK). C. albicans strains were grown in GYNB with or without lactate for 5 h at 37°C, and the cells were washed and resuspended in PBS. Upon arrival, the larvae were kept in wood shavings at 12°C for up to 2 weeks before the experiments. Initially, to compare killing rates for wild-type and deletion strains, groups of 15 larvae weighing 200 to 300 mg were inoculated with 1 × 108, 5 × 107, 5 × 106, and 4 × 105 cells/mL of the wild-type strain. Based on these comparisons, a dose of 2.5 × 105 cells was used in subsequent experiments. Each larva was injected with 50 μL of fungal cell suspension through the second proleg, using a 0.5-mL BD Micro-Fine insulin syringe, and noninjected and PBS controls were included. The larvae were then incubated at 37°C in the dark, and survival was quantified for 10 days postinfection.
+ Open protocol
+ Expand
4

Nanoparticle Delivery via Intravenous, Subcutaneous, and Intranodal Routes

Check if the same lab product or an alternative is used in the 5 most similar protocols
For intravenous injections (iv), mice were warmed either in a heating chamber or under a heating lamp. All the nanoparticles, free antigens or transferred cells were delivered in 200 µL PBS solution through a lateral tail vein by a 1 mL syringe with a 29 G needle.
For subcutaneous injections (sc), under isofluorane anesthesia, nanoparticles or free antigen were delivered in 50 µL PBS solution on the right lateral tail base by a BD Micro-fine + insulin syringe 0.5 mL 30 G. The injection site was briefly massaged to facilitate draining.
For intranodal injections (inod), under isofluorane anesthesia, nanoparticles or free antigen were delivered in 10 µL PBS solution in the right inguinal (subiliac) lymph node by a BD Micro-fine + insulin syringe 0,5 mL 30 G as described in (27). Briefly, a 1–2 cm skin incision was performed, the lymph node was exposed with surgical tweezers followed by injection. Skin wound was closed with either suturing, clips or tissue adhesive (3 M Vetbond).
+ Open protocol
+ Expand
5

Induction of Arthritic Pain in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Complete Freund's adjuvant (CFA) with 1 mg/ml heat-killed Mycobacterium butyricum was commercially available from Sigma and was used in the present study. The protocol of the experiment is shown in Figure 1. As described previously [10 (link)], a mouse model of arthritic joint pain was generated via a single intraarticular injection of 10 μg/10 μl of CFA into the right hindlimb knee joint using an insulin syringe (BD Microfine insulin syringe, 0.3 ml; BD Medical, Oxford, UK), while the mice were briefly anesthetized with isoflurane. Saline (0.9% NaCl) was injected as a control. The day of CFA injection was designated as day 0, and the unilateral monarthritic reaction persisted until approximately day 28 [11 (link)]. Behavioral measurements of hyperalgesia were obtained at baseline and at indicated time points. All experiments were conducted in a blinded manner, and CFA/saline injections were randomly assigned.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!